BioLine RX LtdNASDAQ:BLRXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5299
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.5100/ 50
- Ask / Lots0.5870/ 9
- Open / Previous Close0.0000 / 0.5299
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLRX |
|---|---|---|
| 09:32 ET | 2363 | 0.555 |
| 09:34 ET | 2815 | 0.5426 |
| 09:38 ET | 13937 | 0.5373 |
| 09:39 ET | 5011 | 0.53745 |
| 09:43 ET | 4472 | 0.5301 |
| 09:52 ET | 1627 | 0.537549 |
| 09:57 ET | 20000 | 0.5305 |
| 10:01 ET | 46200 | 0.5449 |
| 10:06 ET | 100 | 0.535 |
| 10:08 ET | 9800 | 0.53995 |
| 10:10 ET | 350 | 0.5376 |
| 10:19 ET | 2100 | 0.535 |
| 10:30 ET | 2000 | 0.535 |
| 10:39 ET | 2000 | 0.54 |
| 10:44 ET | 14181 | 0.54 |
| 10:46 ET | 1000 | 0.5446 |
| 10:50 ET | 4340 | 0.5399 |
| 10:57 ET | 512 | 0.5303 |
| 11:00 ET | 10250 | 0.521 |
| 11:02 ET | 1560 | 0.5299 |
| 11:13 ET | 550 | 0.5209 |
| 11:18 ET | 500 | 0.5209 |
| 11:22 ET | 1400 | 0.5298 |
| 11:27 ET | 500 | 0.5209 |
| 11:31 ET | 4244 | 0.521 |
| 11:33 ET | 3000 | 0.5296 |
| 11:36 ET | 11951 | 0.521 |
| 11:38 ET | 300 | 0.5296 |
| 11:40 ET | 400 | 0.5295 |
| 11:44 ET | 176 | 0.5253 |
| 11:45 ET | 100 | 0.5253 |
| 11:47 ET | 23100 | 0.510001 |
| 11:51 ET | 100 | 0.5101 |
| 11:54 ET | 1100 | 0.5101 |
| 11:56 ET | 2581 | 0.5196 |
| 11:58 ET | 3100 | 0.5197 |
| 12:00 ET | 384 | 0.5194 |
| 12:02 ET | 19999 | 0.5101 |
| 12:03 ET | 5171 | 0.5193 |
| 12:25 ET | 5891 | 0.515 |
| 12:27 ET | 22514 | 0.5107 |
| 12:30 ET | 11629 | 0.5104 |
| 12:32 ET | 1916 | 0.5107 |
| 12:34 ET | 2100 | 0.5106 |
| 12:41 ET | 1400 | 0.5113 |
| 12:43 ET | 1463 | 0.510201 |
| 12:45 ET | 13841 | 0.5252 |
| 12:48 ET | 970 | 0.52 |
| 12:50 ET | 1000 | 0.5203 |
| 12:56 ET | 3300 | 0.52795 |
| 12:57 ET | 500 | 0.5261 |
| 12:59 ET | 290 | 0.5299 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioLine RX Ltd | 48.2M | -0.7x | --- |
Cue Biopharma Inc | 47.7M | -0.9x | --- |
Marker Therapeutics Inc | 46.3M | -3.8x | --- |
LAVA Therapeutics NV | 47.3M | -1.7x | --- |
Dyadic International Inc | 43.3M | -5.4x | --- |
Lipocine Inc | 41.9M | -4.6x | --- |
Company Information
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Contact Information
- Headquarters
- Modi'in Technology Park 2 HaMa'ayan StreetMODIIN, Israel 7177871
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Aharon Schwartz
- Chief Executive Officer
- Philip Serlin
- Chief Financial Officer
- Mali Zeevi
- Vice President - Development
- Ella Sorani
- Vice President-Clinical & Medical Affairs
- Abi Vainstein-Haras
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.2M |
|---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.52 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
